ANIKNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Anika Therapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 29, 2026
$20.22+0.24 (+1.20%)
Close on Oct 19, 2026
- Market cap
- $277.36M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Anika Therapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Quarterly report | 10-Q | Jun 30, 2026 | Jul 29, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 29, 2026 | Jul 29, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 10, 2026 | Jul 14, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 18, 2026 | Jun 23, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | Apr 30, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 24, 2026 | Apr 29, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 18, 2026 | Apr 28, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 3, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 26, 2026 | Feb 26, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 7, 2026 | Jan 8, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 5, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 5, 2025 | Nov 5, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Jul 30, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 30, 2025 | Jul 30, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 30, 2025 | Jul 30, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 20, 2025 | Jun 24, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 9, 2025 | SEC EDGAR |
| Current report | 8-K | May 9, 2025 | May 9, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 20, 2025 | Apr 28, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 4, 2025 | Apr 10, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Mar 17, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 12, 2025 | Mar 12, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 7, 2025 | Mar 11, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 4, 2024 | SEC EDGAR |
| Current report | 8-K | Oct 31, 2024 | Oct 31, 2024 | SEC EDGAR |
| Current report | 8-K | Oct 31, 2024 | Oct 31, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 8, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 8, 2024 | Aug 8, 2024 | SEC EDGAR |
| Current report | 8-K | Jul 9, 2024 | Jul 11, 2024 | SEC EDGAR |
| Proxy statement | DEF 14A | Jul 9, 2024 | Jun 11, 2024 | SEC EDGAR |
| Current report | 8-K | May 28, 2024 | May 28, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2024 | May 8, 2024 | SEC EDGAR |
| Current report | 8-K | May 2, 2024 | May 8, 2024 | SEC EDGAR |
| Current report | 8-K | May 8, 2024 | May 8, 2024 | SEC EDGAR |
| Annual report, amended | 10-K/A | Dec 31, 2023 | Apr 26, 2024 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2023 | Mar 15, 2024 | SEC EDGAR |
| Current report | 8-K | Mar 13, 2024 | Mar 13, 2024 | SEC EDGAR |
| Current report | 8-K | Feb 24, 2024 | Feb 26, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2023 | Nov 3, 2023 | SEC EDGAR |
| Current report | 8-K | Nov 2, 2023 | Nov 2, 2023 | SEC EDGAR |